III

Ault Global Holdings Announces Completion of $200 Million At-The-Market Capital Raise

Retrieved on: 
Friday, November 19, 2021
Technology, Finance, Consulting, Banking, Other Technology, Professional Services, Software, Networks, Hardware, Data Management, Investor relations, Textile, Securities Act of 1933, DPW, Risk, Time, Forward-looking statement, Company, NYSE, ATM, SEC, Program, Nature, U.S. Securities and Exchange Commission, Securities Exchange Act of 1934, View, Investment, Telecommunication, LLC, III, Electric Bond and Share Company v. Securities and Exchange Commission, Suite, Growth, Bank, Financial services, Cryptocurrency

The Company sold the total $200 million at an average price of $3.81 per share.

Key Points: 
  • The Company sold the total $200 million at an average price of $3.81 per share.
  • The shares of common stock were offered through Ascendiant Capital Markets, LLC, in its capacity as the sales agent.
  • Ault Global Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
  • Ault Global Holdings headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141; www.AultGlobal.com .

Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, November 19, 2021
Health, Infectious Diseases, Research, Pharmaceutical, Science, Biotechnology, Private Securities Litigation Reform Act, Safety, Financial compensation, Risk, CureVac, Annual report, Company, Janssen Pharmaceuticals, Cystic Fibrosis Foundation, Fatty liver disease, Duke–NUS Medical School, Severe acute respiratory syndrome coronavirus 2, Johnson & Johnson, SEC, Director, MicroRNA, Therapy, Vaccine, COVID-19, Gene editing, Takeda Pharmaceutical Company, Nasdaq, Twitter, DNA, Glycogen storage disease type III, Patent, RNA, OTC, RNA transfection, NASH, III, Cystic fibrosis, Intention, LinkedIn, Infection, ARCT, Messenger RNA, Employment, Hepatitis B virus, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Liver

The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with the Company.

Key Points: 
  • The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individuals employment compensation and were granted as an inducement material to his or her acceptance of employment with the Company.
  • The options have an exercise price equal to $36.65 per share, the closing price of the Companys common stock as reported by Nasdaq on November 16, 2021.
  • Arcturus versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, replicon RNA, antisense RNA, microRNA, DNA, and gene editing therapeutics.
  • Arcturus technologies are covered by its extensive patent portfolio (patents and patent applications issued in the U.S., Europe, Japan, China and other countries).

AM Best Affirms Credit Ratings of Orion Reinsurance (Bermuda) Ltd.

Retrieved on: 
Thursday, November 18, 2021
Banking, Professional Services, Insurance, Finance, News, Insurance, Bermuda Monetary Authority, Credit, Data, Industry, Income, AM Best, Risk management, ALL, AM, Risk, Good, III, Orion, Life, Growth

AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of bbb- (Good) of Orion Reinsurance (Bermuda) Ltd. (Orion Re) (Hamilton, Bermuda).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of bbb- (Good) of Orion Reinsurance (Bermuda) Ltd. (Orion Re) (Hamilton, Bermuda).
  • The ratings reflect Orion Res balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Ault Global Holdings’ Subsidiary BitNile Purchases 16,000 Bitcoin Miners From BITMAIN, Including S19 XP and S19j Pro Antminers

Retrieved on: 
Thursday, November 18, 2021
Professional Services, Data Management, Technology, Finance, Software, Banking, Investor relations, Textile, Securities Act of 1933, DPW, Technology, Industry, Risk, Forward-looking statement, Company, NYSE, Achievement, Partnership, SEC, Contract, Kilowatt-hour, Nature, U.S. Securities and Exchange Commission, Miner, Securities Exchange Act of 1934, View, Telecommunication, III, Electric Bond and Share Company v. Securities and Exchange Commission, Suite, Multimedia, Growth, Cryptocurrency

Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the Company), announced today that its subsidiary, BitNile, Inc. (BitNile), has entered into contracts with Bitmain Technologies Limited (BITMAIN), to purchase an additional 16,000 Bitcoin miners.

Key Points: 
  • Ault Global Holdings, Inc. (NYSE American: DPW), a diversified holding company (the Company), announced today that its subsidiary, BitNile, Inc. (BitNile), has entered into contracts with Bitmain Technologies Limited (BITMAIN), to purchase an additional 16,000 Bitcoin miners.
  • These purchase agreements represent the achievement of BitNiles stated goal of obtaining no less than 20,000 Bitcoin miners.
  • Ault Global Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
  • Ault Global Holdings headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141; www.AultGlobal.com .

Ault Global Holdings Postpones Investor Conference Call and Webcast to November 22, 2021

Retrieved on: 
Thursday, November 18, 2021
Software, Networks, Finance, Hardware, Banking, Data Management, Professional Services, Technology, Bitcoin, Investor relations, Textile, Risk, DPW, Forward-looking statement, Company, NYSE, Securities Exchange Act of 1934, Nature, U.S. Securities and Exchange Commission, View, Telecommunication, III, Electric Bond and Share Company v. Securities and Exchange Commission, Webcast, Suite, Growth, Securities Act of 1933, Animal, Security (finance)

The Companys Executive Chairman, Milton Todd Ault, III and its CEO, William Horne will be hosting.

Key Points: 
  • The Companys Executive Chairman, Milton Todd Ault, III and its CEO, William Horne will be hosting.
  • Joining Mr. Ault and Mr. Horne will be Kenneth Cragun, the Companys CFO.
  • Ault Global Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact.
  • Ault Global Holdings headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141; www.AultGlobal.com .

EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership

Retrieved on: 
Thursday, November 18, 2021
Oncology, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Patient, Sale, Adoption, PIPE, Technology, Forward-looking statement, Partnership, Form, Madison Avenue, Xi, Frankfurt Stock Exchange, SEC, Proxy, SEC filing, Therapy, EVO, Prospectus, Twitter, Research, Communication, Risk, Biotechnology, Neurology, ISIN, Social media, Instagram, FDA, Science, III, Catalog, Name, LinkedIn, Multimedia, Ix, MDAX, NASDAQ, Failure, Drug discovery, Growth, Securities Act of 1933, Pharmaceutical industry, Fine chemical, Risk management, Book, EQRx, Evotec SE, EQRX, EVOTEC SE

Under the terms of the agreement, EQRx and Evotec will collaborate on drug discovery, pre-clinical and clinical development.

Key Points: 
  • Under the terms of the agreement, EQRx and Evotec will collaborate on drug discovery, pre-clinical and clinical development.
  • Evotec will lead drug discovery and pre-clinical development efforts, and EQRx will be responsible for clinical development, regulatory and commercialization efforts.
  • In addition to jointly funded research and development activities, Evotec will benefit from the potential commercial success of the assets developed within the partnership through a variable profit share mechanism.
  • We continue to rapidly expand our early-stage development pipeline through access to innovative, next-generation drug discovery and engineering technologies, said Carlos Garcia-Echeverria, Ph.D., chief of Rx creation at EQRx.

Moors & Cabot Adds $150m Team, Expanding Midwest Presence

Retrieved on: 
Wednesday, November 17, 2021
KBI, Insurance, Compliance, Moors, Leadership, Goal, Lists of musicians, Maria Moors Cabot Prizes, View, Marketing, Culture, Partner, III, Multimedia, Growth, Financial adviser, Financial services

They currently serve over 400 families and institutions across the U.S., with a strong presence across the Midwest.

Key Points: 
  • They currently serve over 400 families and institutions across the U.S., with a strong presence across the Midwest.
  • I could not be more proud to have such an outstanding team join the Moors & Cabot family."
  • Moors & Cabot CEO Dan Joyce remarked, "We are excited for the addition of Dan, Rob, and Diana to the Moors & Cabot Family.
  • For over 130 years, Moors & Cabot has been a trusted advisor to individuals, families, businesses and institutions in building, managing, protecting and transitioning wealth.

Partnership to End Addiction raises more than $1.4 million at virtual gala hosted by Tamron Hall

Retrieved on: 
Wednesday, November 17, 2021
Sea, Virginia, Connection, CEO, The Walt Disney Company, Grammy Awards, British Inspiration Awards, Time, Addiction, The Bachelorette, III (The Lumineers album), COVID-19, Family, The Lumineers, Hope, Research, Love, III, Tamron Hall, Multimedia, Disney Media and Entertainment Distribution, Pharmaceutical industry, Drug, Tutoring

Emmy Award-winning journalist Tamron Hall hosted the virtual event on Nov. 16.

Key Points: 
  • Emmy Award-winning journalist Tamron Hall hosted the virtual event on Nov. 16.
  • Partnership board member and "America's Most Wanted" host Elizabeth Vargas interviewed Squeri, and Tamron Hall sat down with OConnell.
  • I'm honored to help support Partnership to End Addiction's mission, and especially its messages of love, support and hope," said Hall.
  • Partnership to End Addiction is a national nonprofit uniquely positioned to reach, engage and help families impacted by addiction.

VICTOR F. “TREY” TRAHAN, III, FAIA, SELECTED AS THE 2021 LAUREATE OF THE AMERICAN PRIZE FOR ARCHITECTURE BY BOTH THE CHICAGO ATHENAEUM: MUSEUM OF ARCHITECTURE AND DESIGN AND THE EUROPEAN CENTRE FOR ARCHITECTURE ART DESIGN AND URBAN STUDIES

Associate, United States General Services Administration Building, Civilization, Holabird, General Services Administration, III, Chicago Athenaeum, Kohn Pedersen Fox, City, Architect Magazine, Trahan, CEO, Knowledge, FAIA, New England, Holabird & Root, European Centre for Living Technology, National, Lists of disasters, Cornell University College of Architecture, Art, and Planning, Award, Prize, LA, Environment, GLOBE, Materiality, American Prize for Design, Architect, Innovation, Arquitectonica, Time, American Institute of Architects, Interior design

The Chicago Athenaeum additionally recognized two Trahan Architects projects for American Architecture Awardsthe Ochsner Center for Innovation and the New England Mixed-Use Development.

Key Points: 
  • The Chicago Athenaeum additionally recognized two Trahan Architects projects for American Architecture Awardsthe Ochsner Center for Innovation and the New England Mixed-Use Development.
  • Kindness and compassion are exactly what best exemplify the works of Victor F. Trey Trahan, III, FAIA, stated Christian Narkiewicz-Laine, architecture critic and museum president/CEO of The Chicago Athenaeum.
  • Trahan Architects was founded by Trahan on the belief that the mindful design of everyday spaces can elevate the human experience.
  • Trahan Architects has received over a hundred national, regional and local awards, as well as several international design competitions, including five National AIA Awards.

Thurston Group Exits U.S. Endodontics Partners

Retrieved on: 
Tuesday, November 16, 2021
Smile (Doctor Who), Arc Health, III, Endo, CEO, Knowledge, LLP, Endodontics, Investment, Growth, Louis Leon Thurstone, Multimedia, Willkie Farr & Gallagher, ARC, Health, Sale, Thurston, IRR, History, Physician, Pharmaceutical industry, Dentistry

CHICAGO, Nov. 16, 2021 /PRNewswire/ -- Thurston Group ("Thurston"), a private equity firm focused on investments in healthcare services companies, announced the sale of U.S. Endodontics Partners ("U.S. Endo") to Quad-C Management.

Key Points: 
  • CHICAGO, Nov. 16, 2021 /PRNewswire/ -- Thurston Group ("Thurston"), a private equity firm focused on investments in healthcare services companies, announced the sale of U.S. Endodontics Partners ("U.S. Endo") to Quad-C Management.
  • I feel extreme gratitude for the knowledge, experience and financial win the Thurston Group empowered US Endo partners to achieve."
  • Scotte Hudsmith, U.S. Endo Senior Advisor and Board Member, added, "Thurston Group collaborated with Doctor partners to create US Endo, the first Endodontic Specialty platform.
  • Thurston has an extensive history of partnering with physicians and building fast-growing healthcare businesses, including Smile Doctors, U.S. Endodontics Partners, US Oral Surgery Management, South Georgia Dental Management, U.S. Orthopaedic Partners, Gen4 Dental Partners and ARC Health, among others.